Insider Selling: Trupanion, Inc. (NASDAQ:TRUP) SVP Sells 900 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer sold 900 shares of Trupanion stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $54.55, for a total transaction of $49,095.00. Following the completion of the transaction, the senior vice president now owns 23,808 shares of the company’s stock, valued at $1,298,726.40. This trade represents a 3.64 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Emily Dreyer also recently made the following trade(s):

• On Friday, November 22nd, Emily Dreyer sold 3,100 shares of Trupanion stock. The shares were sold at an average price of $54.85, for a total transaction of $170,035.00.

Trupanion Stock Performance

Shares of Trupanion stock opened at $53.50 on Thursday. The firm has a fifty day moving average of $49.50 and a two-hundred day moving average of $39.97. The stock has a market capitalization of $2.27 billion, a price-to-earnings ratio of -167.19 and a beta of 1.69. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same quarter in the prior year, the company earned ($0.10) EPS. The firm’s quarterly revenue was up 14.6% on a year-over-year basis. As a group, equities research analysts predict that Trupanion, Inc. will post -0.23 EPS for the current year.

Institutional Trading of Trupanion

Large investors have recently made changes to their positions in the company. Quest Partners LLC bought a new stake in shares of Trupanion in the 3rd quarter valued at $37,000. Wilmington Savings Fund Society FSB bought a new stake in shares of Trupanion in the 3rd quarter valued at $54,000. GAMMA Investing LLC increased its position in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after buying an additional 596 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Trupanion in the 2nd quarter valued at $162,000. Finally, Entropy Technologies LP bought a new stake in shares of Trupanion in the 3rd quarter valued at $202,000.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on TRUP shares. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler upped their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Northland Securities upped their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Stifel Nicolaus upped their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Finally, Bank of America upped their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $44.67.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.